Previous 10 |
SAN DIEGO , March 27, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced that its portfolio company AXIM® Biotechnologies ("AXIM ® Biotech" or "AXIM") (OTCQB: AXIM), a world lead...
NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the issuance of a Notice of Allowance for a pat...
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the company has successfully microencapsulated ...
SAN DIEGO , Feb. 14, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States , announced that its subsidiary Kannaway® , the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical...
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the company has received a significant ini...
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent and Trademark Office...
News, Short Squeeze, Breakout and More Instantly...
Axim Biotechnologies Inc Company Name:
AXIM Stock Symbol:
OTCMKTS Market:
Axim Biotechnologies Inc Website:
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM's Diagnostic Research Programs in Dry Eye Disease and Parkinson's SAN DI...
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA - ( NewMediaWire ) - March 27, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,...
The Company’s Commercialization Partner Verséa Ophthalmic Places Re-stock Order of AXIM’s Digital Assay Reader SAN DIEGO, CA - ( NewMediaWire ) - February 20, 2024 - AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,” ...